Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-16T15:32:14.175Z Has data issue: false hasContentIssue false
  • English
  • Français

Safety and efficacy of sedation with propofol for transoesophageal echocardiography in children in an outpatient setting

Published online by Cambridge University Press:  22 March 2006

Christopher R. Mart ,
Mitchell Parrish ,
Kerry L. Rosen ,
Michael D. Dettorre ,
Gary D. Ceneviva ,
Steven E. Lucking  and
Neal J. Thomas
Christopher R. Mart
Affiliation:
Paediatric Cardiology, University of Utah, Salt Lake City, Utah, United States of America
Mitchell Parrish
Affiliation:
School of Medicine, Pennsylvania State University, Hershey, Pennsylvania, United States of America
Kerry L. Rosen
Affiliation:
Paediatric Critical Care, Pennsylvania State University, Hershey, Pennsylvania, United States of America
Michael D. Dettorre
Affiliation:
Paediatric Critical Care, Pennsylvania State University, Hershey, Pennsylvania, United States of America
Gary D. Ceneviva
Affiliation:
Paediatric Critical Care, Pennsylvania State University, Hershey, Pennsylvania, United States of America
Steven E. Lucking
Affiliation:
Paediatric Critical Care, Pennsylvania State University, Hershey, Pennsylvania, United States of America
Neal J. Thomas
Affiliation:
Paediatric Critical Care, Pennsylvania State University, Hershey, Pennsylvania, United States of America
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Transoesophageal echocardiography has become a powerful tool in the diagnosis and management of children with congenital cardiac malformations. Unlike adults, children will not tolerate transoesophageal echocardiography under light sedation. This study was undertaken, therefore, to evaluate the safety and efficacy of deep sedation with propofol for transoesophageal echocardiography in children examined in an outpatient setting. Methods: This is a retrospective study of patients undergoing transoesophageal echocardiography with propofol given in bolus aliquots to achieve a level of sedation adequate to insert the transoesophageal echocardiographic probe and maintain sedation throughout the procedure. Results: We included a total of 118 patients, 57% being male, with a mean age of 12.9 years. Adequate sedation was achieved using a mean propofol dose of 8.3 milligrams per kilogram, with the dose per kilogram decreasing concomitant with increasing weight of the patient. Patients less than two years of age were intubated for the procedure. There were no clinically significant changes in cardiac function or haemodynamics. Non-intubated patients received supplemental oxygen prior to, or just after, the onset of sedation, with transient hypoxaemia observed in one-fifth. Complications were rare, with minor problems occurring in 7.6%, and major ones in 4%. Conclusions: Transoesophageal echocardiography can be performed on an outpatient basis in children with a wide spectrum of congenital cardiac malformations, and propofol is an ideal sedative agent in this setting. Although not common, preparations must be made for significant haemodynamic and respiratory complications. In our study, we intubated all the children under 2 years of age.

Keywords

Paediatric cardiologyanaesthesia, aliquot
Type
Original Article
Information
Cardiology in the Young , Volume 16 , Issue 2 , April 2006 , pp. 152 - 156
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Missri J. Transesophageal Echocardiography – Clinical and Intraoperative Applications. Churchill Livingstone, New York, 1993.
Stumper O, Sutherland GR. Transesophageal echocardiography in congenital heart disease. Edward Arnold, London, 1994.
White PF. Propofol: Pharmacokinetics and Pharmacodynamics. Semin Anesthesia 1988; VII, 1 (Suppl 1): 4–20.Google Scholar
Schmidt C, Roosens C, Struys M, Deryck YL, Van Nooten G, Colardyn JL. Contractility in humans after coronary artery surgery. Anesthesiology 1999; 91: 58–70.Google Scholar
Hammaren E, Hynynen M. Haemodynamic effects of propofol infusion for sedation after coronary artery surgery. Br J Anaesth 1995; 75: 47–50.Google Scholar
Lebovic S, Reich DL, Steinberg LG, Vela FP, Silvay G. Comparison of propofol versus ketamine for anesthesia in pediatric patients undergoing cardiac catheterization. Anesth Analg 1992; 74: 490–494.Google Scholar
Manschot HJ, Meursing AE, Axt P, Byttebier GO, Erdmann W. Propofol requirements for induction of anesthesia in children of different age groups. Anesth Analg 1992; 75: 876–879.Google Scholar
Hertzog JH, Campbell JK, Dalton HJ, Hauser GJ. Propofol anesthesia for invasive procedures in ambulatory and hospitalized children: experience in the pediatric intensive care unit. Pediatrics 1999; 103: E30.Google Scholar
Mulier JP, Wouters PF, Van Aken H, Vermaut G, Vandermeersch E. Cardiodynamic effects of propofol in comparison with thiopental: assessment with a transesophageal approach. Anesth Analg 1991; 72: 28–35.Google Scholar
Bermudez EA, Hui Chen M. Cardiac arrest associated with intravenous propofol during transesophageal echocardiography before DC cardioversion. Heart Dis 2002; 4: 355–357.Google Scholar
Marcus B, Steward DJ, Khan NR, et al. Outpatient transesophageal echocardiography with intravenous Propofol anesthesia in children and adolescents. J Am Soc Echocardiogr 1993; 6: 205–209.Google Scholar
Heard CM, Gunnarsson B, Heard AM, Watson E, Orie JD, Fletcher JE. Paediatr Anaesth 2001; 11: 181–184.Google Scholar
Ferson D, Thakar D, Swafford J, Sinha A, Sapire K, Arens J. Use of deep intravenous sedation with propofol and the laryngeal mask airway during transesophageal echocardiography. J Cardiothorac Vasc Anesth 2003; 17: 443–446.Google Scholar
Frankville DD, Spear RM, Dyck JB. The dose of Propofol required to prevent children from moving during magnetic resonance imaging. Anesthesiology 1993; 79: 953–958.Google Scholar
Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004; 10: 3639–3649.Google Scholar
Crawford MW, Dodgson BG, Holtby HHK, Roy WL. Propofol syndrome in children. CMAJ 2003; 168: 669–670.Google Scholar
Motsch J, Roggenbach J. Propofol infusion syndrome. Anaesthesist 2004; 53: 1009–1022; quiz 1023–1024.Google Scholar
Cray SH, Robinson BH, Cox PN. Lactic academia and bradyarrhythmia in a child sedated with Propofol. Crit Care Med 1998; 26: 2087–2092.Google Scholar
Thompson Micromedex; www.thomsonhc.com/home/dispatch.
Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002; 110: 1177–1181.Google Scholar
Hanna J, Ramundo M. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1994; 50: 301–303.Google Scholar
Parke T, Stevens J, Rice A, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1994; 305: 613–616.Google Scholar
Hertzog J, Dalton H, Anderson B, Shad A, Gootenberg J, Hauser G. Prospective evaluation of propofol anesthesia in the pediatric intensive care unit for elective oncology procedures in ambulatory and hospitalized children. Pediatrics 2000; 106: 742–747.Google Scholar
Ayres NA, Miller-Hance W, et al. Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: report from the task force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 2005; 18: 91–98.Google Scholar